Literature DB >> 19385779

IRB Member Judgments of Decisional Capacity, Coercion, and Risk in Medical and Psychiatric Studies.

Rebecca Luebbert1, Raymond C Tait, John T Chibnall, Teresa L Deshields.   

Abstract

WHILE INDIVIDUALS WITH PSYCHIATRIC illnesses are widely considered a special class of research subjects regarding decisional capacity and coercion vulnerability, those with physical illnesses often are not. IRB members (N = 127) read vignettes that described clinical research targeting one of two levels of disease severity (high/low) for psychiatric or medical diagnoses. They then rated decisional capacity, coercion, and risks for hypothetical research subjects. IRB members viewed psychiatric subjects as having greater vulnerability to coercion and less decisional capacity than medical subjects, even when medical illness was of a severity likely to engender psychiatric comorbidities. These results suggest that IRB members may inflate the vulnerability and decisional incapacity of psychiatric subjects, while discounting vulnerability and incapacity in medical subjects.

Entities:  

Year:  2008        PMID: 19385779      PMCID: PMC3128379          DOI: 10.1525/jer.2008.3.1.15

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  32 in total

1.  Burden of disease--implications for future research.

Authors:  C M Michaud; C J Murray; B R Bloom
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

Review 2.  Informed consent and the capacity for voluntarism.

Authors:  Laura Weiss Roberts
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

3.  IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.

Authors:  Ernest D Prentice; Dean L Antonson; Lyal G Leibrock; Timothy K Kelso; Thomas D Sears
Journal:  IRB       Date:  1993 Sep-Oct

4.  Review of a mock research protocol in functional neuroimaging by Canadian research ethics boards.

Authors:  J de Champlain; J Patenaude
Journal:  J Med Ethics       Date:  2006-09       Impact factor: 2.903

Review 5.  Ethical challenges in stroke research.

Authors:  H Slyter
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

6.  Insights pertaining to patient assessments of states worse than death.

Authors:  R A Pearlman; K C Cain; D L Patrick; M Appelbaum-Maizel; H E Starks; N S Jecker; R F Uhlmann
Journal:  J Clin Ethics       Date:  1993

7.  Desire for hastened death, cancer pain and depression: report of a longitudinal observational study.

Authors:  Sean O'Mahony; Joseph Goulet; Alice Kornblith; Geraldine Abbatiello; Bernadette Clarke; Sarah Kless-Siegel; William Breitbart; Richard Payne
Journal:  J Pain Symptom Manage       Date:  2005-05       Impact factor: 3.612

8.  Do patients with acute medical conditions have the capacity to give informed consent for emergency medicine research?

Authors:  H A Smithline; T J Mader; B J Crenshaw
Journal:  Acad Emerg Med       Date:  1999-08       Impact factor: 3.451

9.  Ovarian cancer patients' psychological distress: the role of physical impairment, perceived unsupportive family and friend behaviors, perceived control, and self-esteem.

Authors:  Tina R Norton; Sharon L Manne; Stephen Rubin; Enrique Hernandez; John Carlson; Cynthia Bergman; Norman Rosenblum
Journal:  Health Psychol       Date:  2005-03       Impact factor: 4.267

10.  Informed consent: assessment of comprehension.

Authors:  D A Wirshing; W C Wirshing; S R Marder; R P Liberman; J Mintz
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

View more
  10 in total

1.  Addressing risks to advance mental health research.

Authors:  Ana S Iltis; Sahana Misra; Laura B Dunn; Gregory K Brown; Amy Campbell; Sarah A Earll; Anne Glowinski; Whitney B Hadley; Ronald Pies; James M Dubois
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

Review 2.  The "Vulnerability" of Psychiatric Research Participants: Why This Research Ethics Concept Needs to Be Revisited.

Authors:  Dearbhail Bracken-Roche; Emily Bell; Eric Racine
Journal:  Can J Psychiatry       Date:  2016-04-05       Impact factor: 4.356

3.  The risk-benefit ratio of studying psychiatric symptoms via daily diary methods.

Authors:  Caitlin Wolford-Clevenger; Mickeah J Hugley; James McNulty; Lawrence Christian Elledge; Karen Cropsey; Gregory L Stuart
Journal:  Account Res       Date:  2019-11-21       Impact factor: 2.622

4.  Assessment of consent capability in psychiatric and medical studies.

Authors:  Raymond C Tait; John T Chibnall; Ana Iltis; Anji Wall; Teresa L Deshields
Journal:  J Empir Res Hum Res Ethics       Date:  2011-03       Impact factor: 1.742

5.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

6.  Restoring balance: a consensus statement on the protection of vulnerable research participants.

Authors:  James M DuBois; Laura Beskow; Jean Campbell; Karen Dugosh; David Festinger; Sarah Hartz; Rosalina James; Charles Lidz
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

7.  Vulnerability in clinical research with patients in pain: a risk analysis.

Authors:  Raymond C Tait
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

8.  Decision-making capacity for research participation among addicted people: a cross-sectional study.

Authors:  Inés Morán-Sánchez; Aurelio Luna; Maria Sánchez-Muñoz; Beatriz Aguilera-Alcaraz; Maria D Pérez-Cárceles
Journal:  BMC Med Ethics       Date:  2016-01-13       Impact factor: 2.652

9.  Applying Genetic and Genomic Tools to Psychiatric Disorders: A Scoping Review.

Authors:  Ana S IItis; Akaya Lewis; Sarah Neely; Stephannie Walker Seaton; Sarah H Jeong
Journal:  HEC Forum       Date:  2021-11-30

10.  Ethical Issues in Research Involving Participants With Opioid Use Disorder.

Authors:  Emily Anderson; Lindsay McNair
Journal:  Ther Innov Regul Sci       Date:  2018-04-08       Impact factor: 1.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.